Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88
Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47
Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53
Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88
Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35
Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.
Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM. Diabetes January 1992 41:118-121; doi:10.2337/diabetes.41.1.118
Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88
Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35
Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88
T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM. Diabetes January 1992 41:118-121; doi:10.2337/diabetes.41.1.118
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.
Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47
Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82
Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.
Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82
Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.
Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62
Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47
Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53
Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107
Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35
Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114
Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53
Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6
Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17
Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114
Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114
T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM. Diabetes January 1992 41:118-121; doi:10.2337/diabetes.41.1.118
Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.
Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62
Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107
Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47
Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76
Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76